Is EyeSci Angels Right for You?

Who We Are Built For

We built EyeSci Angels for accredited investors who value disciplined, domain-specific diligence and want meaningful exposure to early-stage ophthalmology.

EyeSci Angels is a strong fit for:

  • Ophthalmologists and ophthalmic specialists who want to channel domain expertise into informed early-stage investing

  • Life science and healthcare investors seeking focused exposure to ophthalmology with the benefit of clinical and operational diligence

  • Executives and entrepreneurs from the ophthalmic industry who understand the commercialization landscape and want to invest alongside it

  • Sophisticated investors from outside medicine who want focused exposure to ophthalmology on the strength of domain-specific expertise

  • Physicians and professionals who are new to angel investing and want a structured, low-pressure environment in which to learn and engage before deciding how to participate

A Clear-Eyed View of Early-Stage Investing

Early-stage investing in ophthalmology involves real and meaningful risk. Companies fail. Timelines extend. Regulatory paths turn out to be harder than anticipated. These are not hypothetical risks. They are the defining characteristics of the asset class. EyeSci Angels is not the right home for capital you cannot afford to lose or cannot commit for an extended period.

At the same time, early-stage ophthalmology investing offers something later-stage investing does not: access to transformative innovation before institutional capital has already priced in the upside. We are built to help members navigate that tension with clarity and discipline.

What to keep in mind:

  • Investments are illiquid and typically require a long-term perspective of five to ten years, sometimes longer

  • Not every investment will succeed. Portfolio diversification is an important risk management tool.

  • Capital committed to individual investments should be capital you are prepared to have at risk for an extended period

  • We source and evaluate opportunities and share our findings with members. Investment, tax, and legal decisions remain entirely your own.

Accredited Investor Requirement

Membership at EyeSci Angels, at both the Investor and Observer levels, is limited to individuals who qualify as accredited investors under Rule 501 of Regulation D of the U.S. Securities and Exchange Commission (SEC).

In general, an individual qualifies as an accredited investor if they meet one of the following criteria:

Qualification Basis

Criteria

Net Worth

Net worth exceeding $1 million, individually or jointly with a spouse, excluding the value of a primary residence

Income

Annual income exceeding $200,000 individually, or $300,000 jointly with a spouse, in each of the two most recent years, with a reasonable expectation of the same in the current year

Professional Certification

Holding a Series 7, Series 65, or Series 82 license in good standing

Confidentiality and Professional Conduct

Members treat company materials, diligence discussions, and shared insights as confidential. The companies that present to EyeSci Angels do so in good faith, sharing sensitive information with a group they trust to engage responsibly. We hold ourselves and our members to a standard of professionalism and collegiality in every interaction, with company teams and with each other.

Still Not Sure?

That is exactly what Observer Membership is for. If you are uncertain whether EyeSci Angels is the right fit, Observer Membership offers a straightforward way to find out.

Attend presentations. Observe diligence discussions. Engage with the community. Take your time. If it feels like the right group, you will know.

Join Us

Have questions? We’d love to hear from you.